The Investor Day primarily focused on EXXUA™ (gepirone), extended-release tablets ("EXXUA"), the first and only 5HT1a agonist approved by the United States Food and Drug Administration ("FDA") for the ...
Background Patients with severe aortic stenosis (AS) are at high risk of mortality, regardless of symptom status. Despite ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS ...
PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (IPSC)-derived cell therapies for autoimmune diseases and cancer, today announced it has entered into a securities purchase ...
Phasmophobia developers gave us a surprise Christmas gift, stating that 2026 will be the biggest year in the horror game’s history. As the game gets ready to launch on Nintendo Switch 2, developers ...
DENVER(AP) — Jamal Murray and the Denver Nuggets raced out to a 19-0 lead in the opening four minutes and tied a franchise record for 3-pointers with 24, cruising to a 135-112 victory over the Utah ...
Simulation Games Former Stardew Valley dev has to delay adorable new life sim for the second time, shortly after adding the most perfect piles of snow: "I've been working very hard on the game" ...
DALLAS (AP) — Sergei Bobrovsky made 15 saves for his third shutout this season to continue his mastery of Dallas, and Brad Marchand had two goals and an assist as the Florida Panthers blanked the ...
Members of the Windows 1.0 team at their 40-year reunion this week. L-R, kneeling/sitting: Joe Barello, Ed Mills, Tandy Trower, Mark Cliggett, Steve Ballmer (holding a Windows 1.0 screenshot) and Don ...
FDA Clearance Granted After Successful Appeal, Overturning Prior Not Substantially Equivalent (NSE) Outcome HeartBeam’s Credit-Card Sized Device Delivers Clinical-Grade Insights Directly to Patients ...
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
Hosted on MSN
HeartBeam (NASDAQ: BEAT) secures FDA 510(k) clearance for 12-lead ECG synthesis software following successful appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback